Continuing Pharmacy Education for Pharmacy Professionals
Raabe College is committed to assuring that all students receive the finest education possible and is now offering continuing education to pharmacy professionals through distance learning methods. Our faculty members are dedicated scholars with a desire to assist student learning. We welcome your inquiries regarding the profession and our academic program. To learn more, click on any of the listings below.
NOTE: Registering for courses has changed. Once you login to pay for your course, you must remember to write down the enrolment key. You will need the enrolment key to access your course(s). If you already have an enrolment key, click here to access our new course management site.
Fall 2009 Ampul - If you've submitted a hardcopy quiz, credit can only be issed once.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 0048-0000-09-025-H01-P
Course Cost: $10
Krista Davies, Pharm.D., PGY1 Pharmacy Practice Resident, Physicians Inc. and Ohio Northern University
Description:
Diabetic neuropathy is a heterogeneous disease state in which prevention and therapy must be individualized. Diabetic neuropathy is a complication that will continue to increase in prevalence in the future. As healthcare practitioners, we have a duty to educate patients how to minimize their risk for developing diabetic neuropathy and other complications of diabetes.
Objectives:
1. differentiate between autonomic and sensorimotor neuropathy
2. describe different pathologic mechanisms that may contribute to the progression of diabetic neuropathy
3. recognize symptoms associated with diabetic neuropathy
4. recommend appropriate lifestyle modifications to minimize risk for development of diabetic neuropathy
5. educate a patient about proper foot care
6. educate a patient about appropriate treatment options for symptomatic treatment of diabetic neuropathy
7. recommend appropriate therapy for treatment of autonomic symptoms due to diabetic neuropathy
Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.
November 2009 Law & Mortar Newsletter - If you've submitted a hardcopy quiz, credit can only be issued once.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 0048-0000-09-027-H03-P
This program has been approved by the Ohio State Board of Pharmacy for jurisprudence credit. Franklin Z. Wickham, D.Pharm., M.S., R.Ph., previous Director of the Pharmacy Law Institute and previous executive director of the Ohio State Board of Pharmacy.
Description:
This issue of the Law & Mortar completes the series of articles exploring the aberrant practices of businesses that develop, manufacture, and sell prescription drugs at wholesale or retail, as well as those businesses providing professional services by health care professionals. This article continues the discussion begun in the August issue regarding national and regional corporations that own and operate pharmacies in retail establishments, with focus on national and regional discount department stores, warehouse clubs and food chains.
Objectives:
1. describe the different types of discount department stores, warehouse clubs, and food chains operated by large national and regional corporations that include pharmacy departments;
2. explain the state laws and rules governing the practice of pharmacy in these businesses;
3. list the various services offered through these pharmacy websites; and
4. describe the regulation of pharmacies in discount department stores, warehouse clubs, and food chains by federal and state agencies.
Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.
Program length: 0.2 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number:
Course Cost: $20
D. Christopher Hart, Instructor in Pharmacy
Description:
Objectives:
1. Discuss the incidence of chemical dependency in the profession of pharmacy.
2. Describe various risk factors involved in the development of chemical dependency in the profession of pharmacy.
3. Recognize physical symptoms of a chemically dependent pharmacist.
4. Identify behavior patterns that might indicate pharmacist impairment.Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.
May 2009 Law & Mortar Newsletter - If you've submitted a hardcopy quiz, credit can only be issued once.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 048-000-09-017-H03-P
Course Cost: $10
This CE is approved for Ohio Juris Prudence
Franklin Z. Wickham, D.Pharm., M.S., R.Ph., previous Director of the Pharmacy Law Institute and previous executive director of the Ohio State Board of Pharmacy
Description:
This issue of the Law & Mortar continues a series of articles exploring the aberrant practices of businesses that develop, manufacture, and sell prescription drugs at wholesale or retail, as well as those businesses providing professional services by health care professionals. This article focuses on compounding pharmacy practice.
Objectives:
- Define compounding by pharmacists and explain when it is appropriate
- List the types of compounding pharmacies and how they differ
- Explain the various federal and state laws and rules affecting compounding by pharmacists
- List the organizations that provide standards, as well as accreditation/certification of compounding pharmacists and pharmacies
Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.
Spring 2009 Ampule - If you've submitted a hardcopy quiz, credit can only be issued once.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 048-000-09-009-H04-P
Course Cost: $10
Lindsay Snyder, PharmD, Pharmacy Practice resident, Blanchard Valley Medical Associates; Teresa Hoffman, PharmD, site preceptor; and Kelly Shields, PharmD, drug information specialist, ONU preceptor
Objectives:
- Define inactive ingredients
- Describe the purpose of inactive ingredients
- Identify populations in which inactive ingredients are
of concern
- Recognize potential inactive ingredient problems in
those populations
- Formulate a plan to respond to inquiries about inactive
ingredients
November 2008 Law & Mortar Newsletter - If you've submitted a hardcopy quiz, credit can only be issued once.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
This CE is approved for Ohio Juris Prudence.
Universal Activity Number: 048-000-08-045-H03-P
Course Cost: $10
Franklin Z. Wickham, D.Pharm., M.S., R.Ph., previous Director of the Pharmacy Law Institute and previous executive director of the Ohio State Board of Pharmacy
Objectives:
At the completion of this program, the participant will be able to:
- Explain the application of general business principles to the health care industry.
- Identify federal and state government agencies impacting development, manufacture and legal distribution of pharmaceuticals.
- Describe the background of patent law and list specific examples that apply to pharmaceutical manufacturers maintaining economic advantage.
- Outline the adoption and repeal of state anti-substitution laws.
-. List effective prescription drug marketing strategies.
August 2008 Law & Mortar Newsletter - If you've submitted a hardcopy quiz, credit can only be issued once.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
This CE is approved for Ohio juris prudence.
Universal Activity Number: 048-000-08-035-H03-P
Course Cost: $10
Franklin Z. Wickham, D.Pharm., M.S., R.Ph., previous Director of the Pharmacy Law Institute and previous executive director of the Ohio State Board of Pharmacy
Objectives:
At the completion of this program, the participant will be able to:
- Explain the application of general business principles to the health care industry.
- Identify federal and state government agencies impacting development, manufacture and legal distribution of pharmaceuticals.
- Describe the background of patent law and list specific examples that apply to pharmaceutical manufacturers maintaining economic advantage.
- Outline the adoption and repeal of state anti-substitution laws.
-. List effective prescription drug marketing strategies.
Fall 2008 Ampule - If you've submitted a hardcopy quiz, credit can only issued once.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 048-000-08-042-H103-P
Course Cost: $10
Danielle Fennema, PharmD, Pharmacy Practice Resident at Physicians Inc/Ohio Northern University
With: Michael Rush, PharmD, Preceptor at Physicians Inc and Kelly Shields, PharmD, Director of Drug Information Services at Ohio Northern University
This article is designed to provide a brief review of heart failure and its major components that include pathophysiology, causes, diagnosis and testing, heart failure classifications, and treatments. The treatment options are divided into non-pharmacologic versus pharmacologic.
Objectives:
At the completion of this program, the participant will be able to:
- Recognize signs and symptoms of left and right ventricular heart failure.
- Identify causes of heart failure.
- List the ACC/AHA heart failure stages.
- Recognize the clinical trials supporting the ACC/AHA heart failure guidelines.
- The material presented was unbiased.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 048-000-07-030-H01-P
Course Cost: $10
Program Length: 0.1 CEU
Target Audience: Pharmacists
Description:
Dr. Martin, Assistant Professor of Pharmacy Practice, discusses the definition, prevention, pharmacologic therapy, and non-pharmacologic therapy for migraine headaches.
Objectives:
-Describe current trends in the use of pharmacotherapy for migraine prevention.
-Explain the indications for, goals of, and potential benefits of the use of pharmacotherapy for migraine prevention.
-Explain factors to consider in the use and selection of pharmacotherapy for migraine prevention.
-Identify pros and cons of the currently available pharmacologic options for migraine prevention.
-Describe how to assess efficacy and tolerability of medications used in migraine prevention.
-Educate patients on the use of both acute and preventive migraine pharmacotherapy.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 048-000-07-028-L01-P
Course Cost: $10
Description:
Dr. Roecker, Associate Professor of Pharmacy Practice, discusses the epidemiology, at risk populations, pathogenesis, and treatment of community acquired pneumonia.
Objectives:
At the completion of this program, the participant will be able to:
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 048-000-07-024-H04
Course Cost: $10
Description:
Dr. Shields, Assistant Professor of Pharmacy Practice, Director of The Drug Information Center, discusses the use, epidemiology, product regulation, purity, standardization, information resources, and pharmacists' role regarding dietary supplements.
Objectives:
At the completion of this program, the participant will be able to:
-Describe the prevalence and factors impacting patient use of dietary supplements.
-Identify issues of product quality related to dietary supplements.
-Identify current programs assessing product quality.
-Describe the role of the pharmacist in providing care to patients using supplements.
-Describe patient communication techniques for patients using supplements.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 048-000-07-029-H01-P
Course Cost: $10
Description:
Dr. Stockert, assistant professor of biochemistry, reviews enzyme catalysis, transition state theory, and enzyme kinetics.
Objectives:
At the completion of this program, the participant will be able to:
-Review the basics of enzyme catalysis including transition state theory.
-List four major methods utilized by enzymes for stabilization of the transition state: 1) proximity effects 2) acid-base catalysis 3) covalent catalysis 4) strain.
-Differentiate between steady state and pre-steady state kinetics.
-Differentiate between zero-order and first-order kinetics on the Michaelis-Menton graph.
-Given a Michaelis-Menton graph or Lineweaver-Burke plot, identify the Vmax and Km.
-List three classes of inhibitors: 1) competitive 2) non-competitive and 3) un-competitive.
-Given a Michaelis-Menton graph or Lineweaver-Burke plot, identify the type of inhibition.
-List the necessity of pre-steady state kinetics for design of mechanism based inhibitors.
Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.
System: Retail and Specialty Pharmacies
Law & Mortar Newsletter - If you've submitted a hardcopy quiz, credit can only be issued once.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 048-000-08-029-H03-P
Course Cost: $10
Description:
The goal of this CLE article is to
discuss the background of retail health
clinics and various models currently in
operation in Ohio; the laws and rules governing
the prescribing and utilization of
drugs by mid-level prescribers whose professional
practice occurs in retail establishments;
and the scope of professional practice
of these health professionals (nurses
and optometrists), including prescriptive
authority.
Objectives:
- State background information on retail health clinics from patient, employer, and insurer standpoints;
- List the major companies in Ohio with retail health clinics and compare their work models and staffing;
- Explain Ohio law concerning credentialing,certification, and scope of practice of nurse practitioners;
- Describe CVS Caremark’s MinuteClinic model; and
- Explain the scope of practice of optometrists practicing in vision care centers in retail health clinics, including H.B. 149 scope update.
Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.
Spring 2008 Ampule - If you've submitted a hardcopy quiz, credit can only issued once.
Program length: 0.1 CEU
Target audiences: Pharmacists
Knowledge based activity
Universal Activity Number: 048-000-08-017-H01-P
Course Cost: $10
Description:
Mary Ann Tucker, PharmD, Pharmacy Practice resident, Blanchard Valley Medical Associates; Teresa Hoffman, Pharmd, site preceptor; and Kelly Shields, PharmD drug information specialist, ONU preceptor present and discuss Amiodarone (Cordarone®, Pacerone®), one of the most widely used antiarrhythmic medications and the pharmacist's vital role in ensuring proper use and monitoring of the drug.
Objectives:
Understand the various labeled and unlabeled uses of amiodarone.
Understand the unique mechanism of action and pharmacokinetics of amiodarone and how these factors impact adverse reactions.
Identify the most common adverse drug reactions associated with amiodarone.
Identify necessary monitoring for a patient on long-term amiodarone therapy.
Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.